Last reviewed · How we verify
Aquaphor
At a glance
| Generic name | Aquaphor |
|---|---|
| Also known as | petrolatum |
| Sponsor | Johns Hopkins Bloomberg School of Public Health |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)
- Comparison of ESWT and Deep Tissue Massage in Individuals With Medial Tibial Stress Syndrome (NA)
- A Bioelectric Dressing for Post De-Roofing Treatment of HS (NA)
- Skin Barrier Function and Inflammation in Aging: The BIA Study (PHASE4)
- Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals. (NA)
- Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel) (NA)
- Silicone Gel for Postsurgical Scars of the Eyelid (NA)
- CO2Lift and T-Junction Breakdown Rates Evaluation After Breast Reduction Surgery Pilot Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aquaphor CI brief — competitive landscape report
- Aquaphor updates RSS · CI watch RSS
- Johns Hopkins Bloomberg School of Public Health portfolio CI